MORPHOCHEM AKTIENGESELLSCHAFT FUER KOMB CHEMIE has a total of 17 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, United States and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are JW PHARMACEUTICAL CORP, APPLIED THERAPEUTICS INC and COLBY PHARMACEUTICAL COMPANY.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | United States | 4 | |
#3 | Brazil | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | New Zealand | 2 | |
#6 | China | 1 | |
#7 | Mexico | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Dalhoff Axel | 8 |
#2 | Kapsner Thomas | 7 |
#3 | Thomas Kapsner | 5 |
#4 | Gramatte Thomas | 5 |
#5 | Axel Dalhoff | 4 |
#6 | Specklin J L | 3 |
#7 | Hubschwerlen Christian | 3 |
#8 | Thomas Gramatte | 2 |
#9 | Schmitt Christine | 2 |
#10 | Cappi Michael | 2 |
Publication | Filing date | Title |
---|---|---|
US2016130288A1 | Oxazolidinone-quinolone hybrid antibacterials for the parenteral treatment or prophylaxis of bacterial diseases | |
AU2011202771A1 | Oxazolidinone-quinolone hybrid antibiotics | |
AU2004299278A1 | Oxazolidinone-quinolone hybrid antibiotics |